Literature DB >> 15390041

Cannabis sativa and dystonia secondary to Wilson's disease.

M Claudia Uribe Roca1, Federico Micheli, Ricardo Viotti.   

Abstract

A patient with generalized dystonia due to Wilson's disease obtained marked improvement in response to smoking cannabis. (c) 2004 Movement Disorder Society.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15390041     DOI： 10.1002/mds.20268

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  7 in total

Review 1.  Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics.

Authors:  Barbara S Koppel
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  A case of Wilson's disease presenting with paroxysmal dystonia.

Authors:  Hyun Jae Kim; Jung Han Yoon
Journal:  Neurol Sci       Date:  2017-05-30       Impact factor: 3.307

Review 3.  Cannabinoids and dystonia: an issue yet to be defined.

Authors:  Marcello Mario Mascia; Daniele Carmagnini; Giovanni Defazio
Journal:  Neurol Sci       Date:  2019-12-17       Impact factor: 3.307

4.  Cannabinoids for the Treatment of Movement Disorders.

Authors:  Briony Catlow; Juan Sanchez-Ramos
Journal:  Curr Treat Options Neurol       Date:  2015-09       Impact factor: 3.598

Review 5.  The therapeutic potential of cannabinoids for movement disorders.

Authors:  Benzi Kluger; Piera Triolo; Wallace Jones; Joseph Jankovic
Journal:  Mov Disord       Date:  2015-02-04       Impact factor: 10.338

Review 6.  Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.

Authors:  Mariana Babayeva; Haregewein Assefa; Paramita Basu; Sanjeda Chumki; Zvi Loewy
Journal:  Parkinsons Dis       Date:  2016-12-05

Review 7.  Medical treatment of dystonia.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2016-12-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.